Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
4579.T Stock Summary
Top 10 Correlated ETFs
4579.T
In the News
4579.T Financial details
Company Rating
Buy
Market Cap
15.63B
Income
279.38M
Revenue
2.48B
Book val./share
300.65
Cash/share
176.52
Dividend
-
Dividend %
-
Employees
65
Optionable
No
Shortable
Yes
Earnings
09 Nov 2023
P/E
57.48
Forward P/E
-
PEG
-9.13
P/S
6.46
P/B
2.47
P/C
4.17
P/FCF
-178457.87
Quick Ratio
14.46
Current Ratio
14.77
Debt / Equity
0.04
LT Debt / Equity
0.03
-
-
EPS (TTM)
13.37
EPS next Y
-
EPS next Q
-
EPS this Y
-4.35%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
NAN%
Revenue last 5Y
31.41%
Revenue Q/Q
73.71%
EPS Q/Q
-217.15%
-
-
-
-
SMA20
-3.2%
SMA50
1.84%
SMA100
-8.56%
Inst Own
-
Inst Trans
-
ROA
4%
ROE
5%
ROC
0.02%
Gross Margin
90%
Oper. Margin
6%
Profit Margin
11%
Payout
-
Shs Outstand
21.62M
Shs Float
17.63M
-
-
-
-
Target Price
-
52W Range
663.0-1421.0
52W High
-48.21%
52W Low
+11.01%
RSI
48.84
Rel Volume
0.54
Avg Volume
134.73K
Volume
72.3K
Perf Week
-1.21%
Perf Month
2.36%
Perf Quarter
-12.17%
Perf Half Y
-10.9%
-
-
-
-
Beta
0.834459
-
-
Volatility
11.61%, 15.99%
Prev Close
-1.47%
Price
736
Change
-1.08%
4579.T Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2022-12-31
Metric | History | 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 |
---|---|---|---|---|---|---|
Revenue per share | 36.55 | 82.71 | 52.85 | 132.5 | 139.16 | |
Net income per share | -54.23 | 0.26 | -28.97 | 36.07 | 34.5 | |
Operating cash flow per share | -19.83 | -25.78 | -13.8 | 17.47 | 70.58 | |
Free cash flow per share | -30.69 | -30.37 | -21.27 | 12.44 | 69.06 | |
Cash per share | 90.31 | 106.86 | 100.88 | 126.91 | 187.23 | |
Book value per share | 189.36 | 224.42 | 191.46 | 228.51 | 262.14 | |
Tangible book value per share | 187.69 | 222.85 | 189.88 | 226.9 | 260.98 | |
Share holders equity per share | 189.36 | 224.42 | 191.46 | 228.51 | 262.14 | |
Interest debt per share | 0.15 | 0.12 | 2.19 | 1.93 | 10.89 | |
Market cap | 21.94B | 27.61B | 20.95B | 24.6B | 25.83B | |
Enterprise value | 20.27B | 25.44B | 19.6B | 22.29B | 22.38B | |
P/E ratio | -19.86 | 5.17K | -34.52 | 32.55 | 35.71 | |
Price to sales ratio | 29.46 | 16.21 | 18.92 | 8.86 | 8.85 | |
POCF ratio | -54.3 | -52.01 | -72.44 | 67.21 | 17.45 | |
PFCF ratio | -35.09 | -44.16 | -47.02 | 94.39 | 17.84 | |
P/B Ratio | 5.69 | 5.98 | 5.22 | 5.14 | 4.7 | |
PTB ratio | 5.69 | 5.98 | 5.22 | 5.14 | 4.7 | |
EV to sales | 27.22 | 14.94 | 17.7 | 8.03 | 7.67 | |
Enterprise value over EBITDA | -21.67 | 222.73 | -48.55 | 21.92 | 21.21 | |
EV to operating cash flow | -50.17 | -47.92 | -67.78 | 60.9 | 15.12 | |
EV to free cash flow | -32.42 | -40.69 | -43.99 | 85.54 | 15.45 | |
Earnings yield | -0.05 | 0 | -0.03 | 0.03 | 0.03 | |
Free cash flow yield | -0.03 | -0.02 | -0.02 | 0.01 | 0.06 | |
Debt to equity | 0 | 0 | 0.01 | 0.01 | 0.04 | |
Debt to assets | 0 | 0 | 0.01 | 0.01 | 0.04 | |
Net debt to EBITDA | 1.78 | -19.02 | 3.34 | -2.27 | -3.27 | |
Current ratio | 11.93 | 16.75 | 15.18 | 10 | 9.77 | |
Interest coverage | 0 | 0 | -1.11K | 486.84 | 144.49 | |
Income quality | 0.37 | -19.44 | 0.55 | 0.42 | 1.74 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0.88 | 0.35 | 0.47 | 0.22 | 0.2 | |
Research and developement to revenue | 1.44 | 0.51 | 0.84 | 0.41 | 0.43 | |
Intangibles to total assets | 0.01 | 0.01 | 0.01 | 0.01 | 0 | |
Capex to operating cash flow | 0.55 | 0.18 | 0.54 | -0.29 | -0.02 | |
Capex to revenue | -0.3 | -0.06 | -0.14 | -0.04 | -0.01 | |
Capex to depreciation | -1.76 | -0.67 | -1.26 | -0.74 | -0.22 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 480.67 | 36.2 | 353.28 | 430.65 | 451.08 | |
ROIC | -0.29 | 0 | -0.14 | 0.12 | 0.12 | |
Return on tangible assets | -0.27 | 0 | -0.14 | 0.15 | 0.12 | |
Graham Net | 83.88 | 126.47 | 111.68 | 152.82 | 179.8 | |
Working capital | 1.8B | 2.88B | 2.65B | 3.6B | 4.33B | |
Tangible asset value | 3.82B | 4.59B | 3.98B | 4.75B | 5.47B | |
Net current asset value | 1.77B | 2.85B | 2.59B | 3.56B | 4.06B | |
Invested capital | 0 | 0 | 0.01 | 0.01 | 0.04 | |
Average receivables | 390.99M | 451.9M | 719.96M | 964.6M | 1.06B | |
Average payables | 992K | 17.15M | 38.06M | 43.91M | 87.03M | |
Average inventory | 5.83M | 6M | 6.02M | 8.54M | 9.52M | |
Days sales outstanding | 39.88 | 176.28 | 203.54 | 172.46 | 100.16 | |
Days payables outstanding | 0 | 47.63 | 110.63 | 52.35 | 201.84 | |
Days of inventory on hand | 26.53 | 7.64 | 17.3 | 12 | 13.4 | |
Receivables turnover | 9.15 | 2.07 | 1.79 | 2.12 | 3.64 | |
Payables turnover | 0 | 7.66 | 3.3 | 6.97 | 1.81 | |
Inventory turnover | 13.76 | 47.78 | 21.1 | 30.4 | 27.25 | |
ROE | -0.29 | 0 | -0.15 | 0.16 | 0.13 | |
Capex per share | -10.86 | -4.58 | -7.46 | -5.03 | -1.52 |
Quarterly Fundamentals Overview
Last date of statement is 2023-06-30 for Q2
Metric | History | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 |
---|---|---|---|---|---|---|
Revenue per share | 13.76 | 5.68 | 48.34 | 17.17 | 29.78 | |
Net income per share | 7.33 | -0.03 | 12.22 | -6.88 | 8.04 | |
Operating cash flow per share | 2.95 | 4.26 | 25.15 | -9.76 | -23.35 | |
Free cash flow per share | 2.79 | 4.08 | 24.9 | -11.32 | -28.07 | |
Cash per share | 41.43 | 46.63 | 187.23 | 210.01 | 176.52 | |
Book value per share | 65.31 | 65.16 | 262.14 | 289.74 | 300.65 | |
Tangible book value per share | 64.95 | 64.82 | 260.98 | 288.02 | 299.07 | |
Share holders equity per share | 65.31 | 65.16 | 262.14 | 289.74 | 300.65 | |
Interest debt per share | 3.16 | 3.01 | 10.69 | 12.15 | 11.49 | |
Market cap | 56.76B | 84.06B | 25.83B | 18.08B | 15.97B | |
Enterprise value | 53.85B | 80.74B | 22.38B | 14.07B | 12.67B | |
P/E ratio | 24.04 | -9.04K | 25.21 | -30.46 | 22.97 | |
Price to sales ratio | 51.23 | 183.88 | 25.48 | 48.8 | 24.82 | |
POCF ratio | 239.32 | 245.11 | 48.99 | -85.82 | -31.65 | |
PFCF ratio | 252.46 | 255.71 | 49.48 | -74.02 | -26.33 | |
P/B Ratio | 10.79 | 16.02 | 4.7 | 2.89 | 2.46 | |
PTB ratio | 10.79 | 16.02 | 4.7 | 2.89 | 2.46 | |
EV to sales | 48.6 | 176.63 | 22.08 | 37.97 | 19.69 | |
Enterprise value over EBITDA | 65.51 | -118.92K | 87.75 | -189.51 | 58.06 | |
EV to operating cash flow | 227.04 | 235.45 | 42.45 | -66.78 | -25.11 | |
EV to free cash flow | 239.5 | 245.63 | 42.87 | -57.6 | -20.89 | |
Earnings yield | 0.01 | 0 | 0.01 | -0.01 | 0.01 | |
Free cash flow yield | 0 | 0 | 0.02 | -0.01 | -0.04 | |
Debt to equity | 0.05 | 0.05 | 0.04 | 0.04 | 0.04 | |
Debt to assets | 0.04 | 0.04 | 0.04 | 0.04 | 0.03 | |
Net debt to EBITDA | -3.54 | 4.88K | -13.54 | 54.03 | -15.11 | |
Current ratio | 10.56 | 13.05 | 9.77 | 14.1 | 14.77 | |
Interest coverage | 358.97 | -29.9 | 123.78 | -72.26 | 56.22 | |
Income quality | 0.31 | -102.34 | 2.96 | 1.91 | -3.44 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0.11 | 0.29 | 0.17 | 0.41 | 0.25 | |
Research and developement to revenue | 0.24 | 0.68 | 0.4 | 0.72 | 0.52 | |
Intangibles to total assets | 0 | 0 | 0 | 0.01 | 0 | |
Capex to operating cash flow | -0.05 | -0.04 | -0.01 | 0.16 | 0.2 | |
Capex to revenue | -0.01 | -0.03 | -0.01 | -0.09 | -0.16 | |
Capex to depreciation | -0.33 | -0.37 | -0.13 | -1.08 | -2.5 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 103.81 | 6.51 | 268.46 | 211.74 | 233.27 | |
ROIC | 0.09 | -0.01 | 0.05 | -0.02 | 0.01 | |
Return on tangible assets | 0.1 | 0 | 0.04 | -0.02 | 0.02 | |
Graham Net | 43.52 | 46.13 | 179.8 | 199.74 | 188.77 | |
Working capital | 4.1B | 4.24B | 4.33B | 4.92B | 4.86B | |
Tangible asset value | 5.23B | 5.22B | 5.47B | 6.21B | 6.46B | |
Net current asset value | 3.86B | 3.99B | 4.06B | 4.59B | 4.51B | |
Invested capital | 0.05 | 0.05 | 0.04 | 0.04 | 0.04 | |
Average receivables | 886.58M | 934.42M | 772.89M | 720.65M | 965M | |
Average payables | 57.29M | 63.07M | 99M | 94.84M | 64.98M | |
Average inventory | 8.96M | 8.76M | 8.84M | 8.53M | 8.47M | |
Days sales outstanding | 91.29 | 146.68 | 71.09 | 155.6 | 180.32 | |
Days payables outstanding | 98.45 | 99.3 | 181.22 | 93.31 | 97.87 | |
Days of inventory on hand | 14.62 | 13.03 | 12.03 | 12.98 | 11.98 | |
Receivables turnover | 0.99 | 0.61 | 1.27 | 0.58 | 0.5 | |
Payables turnover | 0.91 | 0.91 | 0.5 | 0.96 | 0.92 | |
Inventory turnover | 6.15 | 6.91 | 7.48 | 6.94 | 7.51 | |
ROE | 0.11 | 0 | 0.05 | -0.02 | 0.03 | |
Capex per share | -0.15 | -0.18 | -0.25 | -1.56 | -4.72 |
4579.T Frequently Asked Questions
What is RaQualia Pharma Inc. stock symbol ?
RaQualia Pharma Inc. is a JP stock and trading under the symbol 4579.T
What is RaQualia Pharma Inc. stock quote today ?
RaQualia Pharma Inc. stock price is $736 today.
Is RaQualia Pharma Inc. stock public?
Yes, RaQualia Pharma Inc. is a publicly traded company.